- E-postKristin.Varhaug@uib.no
- BesøksadresseHaukeland Universitetssykehus Laboratoriebygget, 7. etg. Heis øst5009 Bergen
- PostadressePostboks 78045020 Bergen
Vitenskapelig artikkel
- (2022). The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. Cell Metabolism. 396-407.e6.
- (2020). Using urine to diagnose large-scale mtDNA deletions in adult patients. Annals of clinical and translational neurology. 1318-1326.
- (2020). Safety of drug use in patients with a primary mitochondrial disease: An international Delphi-based consensus. The Journal of Inherited Metabolic Disease (JIMD). 800-818.
- (2020). Polymerase gamma-relatert mitokondriesykdom. Tidsskrift for Den norske legeforening. 1-7.
- (2020). Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis. Frontiers in Neurology. 7 sider.
- (2019). Mitochondrial complex IV is lost in neurons in the cuprizone mouse model. Mitochondrion (Amsterdam. Print). 58-62.
- (2017). Neurofilament light chain predicts disease activity in relapsing-remitting MS. Neurology: Neuroimmunology and neuroinflammation. 1-8.
- (2017). Multippel sklerose - en mitokondriemediert sykdom? Tidsskrift for Den norske legeforening. 274-287.
- (2016). Increased levels of cell-free mitochondrial DNA in the cerebrospinal fluid of patients with multiple sclerosis. Mitochondrion (Amsterdam. Print). 32-35.
Brev til redaktøren
- (2021). Comment on “A severe linezolid-induced rhabdomyolysis and lactic acidosis in Leigh syndrome”. The Journal of Inherited Metabolic Disease (JIMD). 6-7.
Vitenskapelig oversiktsartikkel/review
- (2019). Neurofilament light chain as a biomarker in multiple sclerosis. Frontiers in Neurology. 1-6.